In what ways could the amendments to the New Drugs and Clinical Trials Rules, 2019, change the balance between innovation and patient safety?
The Health Ministry has notified amendments to clinical trial rules. I want to analyze how these changes might influence drug development, ethical standards, and the protection of trial participants in India.